P2X receptors mediated abnormal interaction between satellite glial cells and neurons in visceral pathological

Zilin Wang1, Lin Li2,3, Runan Yang2,3

  • 1Undergraduate student of class 156 of Nanchang University Queen Marry University of London Joint programme, Nanchang University, Nanchang, 330006, Jiangxi, People's Republic of China.

Insights

Adenosine triphosphate (ATP)-gated P2X receptors are crucial ion channels involved in pain and heart function. This review explores their role in neuronal-glial interactions and visceral pathologies like myocardial ischemia.

Area of Science:

  • Neuroscience
  • Physiology
  • Pharmacology

Background:

  • P2X receptors are ligand-gated ion channels activated by extracellular adenosine triphosphate (ATP).
  • These trimer channels, assembled from seven subunits, are found in mammals and increasingly in non-vertebrates.
  • P2X receptors play vital roles in physiological processes, including cardiac function and pain regulation.

Purpose of the Study:

  • To review current research on P2X receptor regulation.
  • To examine the involvement of P2X receptors in abnormal neuronal-glial interactions.
  • To investigate the role of P2X receptors in visceral pathologies, particularly myocardial ischemia.

Main Methods:

  • Literature review of current studies on P2X receptors.
  • Analysis of P2X receptor involvement in neuronal-glial signaling.
  • Examination of P2X receptor function in visceral disease models.

Main Results:

  • P2X receptors are implicated in the regulation of pain, chronic pain, and glial integration.
  • Dysregulation of P2X receptors contributes to abnormal neuronal-glial interactions.
  • P2X receptor activity is altered in pathological conditions affecting viscera, such as myocardial ischemia.

Conclusions:

  • P2X receptors are key players in both normal physiology and disease states.
  • Understanding P2X receptor regulation is critical for developing treatments for chronic pain and visceral pathologies.
  • Further research into P2X receptors in myocardial ischemia and neuronal-glial interactions is warranted.

Related Concept Videos

Receptor-mediated Endocytosis01:39

Receptor-mediated Endocytosis

Overview
110.7K
Receptor-mediated Endocytosis01:20

Receptor-mediated Endocytosis

Receptor-mediated endocytosis is when bulk amounts of specific molecules are imported into a cell after binding to cell surface receptors. The molecules bound to these receptors are taken into the cell through inward folding of the cell surface membrane, which is eventually pinched off into a vesicle within the cell. Structural proteins, such as clathrin, coat the budding vesicle.
Clathrin-Mediated Endocytosis of LDL
One well-characterized example of receptor-mediated endocytosis is the...
7.6K
Glial Cells01:04

Glial Cells

Overview
93.3K
Drug-Receptor Interactions01:29

Drug-Receptor Interactions

Drug-receptor interaction describes the binding of receptors by drugs, but not all drug-receptor interactions result in activation and tissue response. For instance, the binding of agonists activates the receptor to generate a cellular reaction, while antagonists bind to receptors without causing their activation.
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
7.4K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.1K
Drug-Receptor Interaction: Antagonist01:28

Drug-Receptor Interaction: Antagonist

An antagonist is a drug that binds strongly to a receptor without activating it. An antagonist prevents other molecules, such as neurotransmitters or hormones, from binding to the receptor and triggering a cellular response. Such interaction effectively hinders the normal physiological processes mediated by the receptor, resulting in various pharmacological effects depending on the specific receptor targeted.
Antagonists can be classified as competitive or noncompetitive based on their...
5.0K